348 related articles for article (PubMed ID: 32732334)
61. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.
Horeweg N; van der Aalst CM; Thunnissen E; Nackaerts K; Weenink C; Groen HJ; Lammers JW; Aerts JG; Scholten ET; van Rosmalen J; Mali W; Oudkerk M; de Koning HJ
Am J Respir Crit Care Med; 2013 Apr; 187(8):848-54. PubMed ID: 23348977
[TBL] [Abstract][Full Text] [Related]
62. Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial.
Nestle U; Schimek-Jasch T; Kremp S; Schaefer-Schuler A; Mix M; Küsters A; Tosch M; Hehr T; Eschmann SM; Bultel YP; Hass P; Fleckenstein J; Thieme A; Stockinger M; Dieckmann K; Miederer M; Holl G; Rischke HC; Gkika E; Adebahr S; König J; Grosu AL;
Lancet Oncol; 2020 Apr; 21(4):581-592. PubMed ID: 32171429
[TBL] [Abstract][Full Text] [Related]
63. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
[TBL] [Abstract][Full Text] [Related]
64. Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial.
Brain K; Lifford KJ; Carter B; Burke O; McRonald F; Devaraj A; Hansell DM; Baldwin D; Duffy SW; Field JK
Thorax; 2016 Nov; 71(11):996-1005. PubMed ID: 27471048
[TBL] [Abstract][Full Text] [Related]
65. Early detection of lung cancer in Czech high-risk asymptomatic individuals (ELEGANCE): A study protocol.
Lambert L; Janouskova L; Novak M; Bircakova B; Meckova Z; Votruba J; Michalek P; Burgetova A
Medicine (Baltimore); 2021 Feb; 100(5):e23878. PubMed ID: 33592843
[TBL] [Abstract][Full Text] [Related]
66. Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker study.
Carozzi FM; Bisanzi S; Carrozzi L; Falaschi F; Lopes Pegna A; Mascalchi M; Picozzi G; Peluso M; Sani C; Greco L; Ocello C; Paci E;
Int J Cancer; 2017 Jul; 141(1):94-101. PubMed ID: 28387927
[TBL] [Abstract][Full Text] [Related]
67. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
68. Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial.
Navani N; Nankivell M; Lawrence DR; Lock S; Makker H; Baldwin DR; Stephens RJ; Parmar MK; Spiro SG; Morris S; Janes SM;
Lancet Respir Med; 2015 Apr; 3(4):282-9. PubMed ID: 25660225
[TBL] [Abstract][Full Text] [Related]
69. Initial Results from Mobile Low-Dose Computerized Tomographic Lung Cancer Screening Unit: Improved Outcomes for Underserved Populations.
Raghavan D; Wheeler M; Doege D; Doty JD; Levy H; Dungan KA; Davis LM; Robinson JM; Kim ES; Mileham KF; Oliver J; Carrizosa D
Oncologist; 2020 May; 25(5):e777-e781. PubMed ID: 31771991
[TBL] [Abstract][Full Text] [Related]
70. The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial.
Cotter A; Wallace D; McCarthy C; Feeney E; O'Neill L; Stack J; McCarthy G; Hussain R; Alvarez Barco E; Doran P; Mallon P
Trials; 2020 Sep; 21(1):758. PubMed ID: 32883328
[TBL] [Abstract][Full Text] [Related]
71. Association of Stage Shift and Population Mortality Among Patients With Non-Small Cell Lung Cancer.
Flores R; Patel P; Alpert N; Pyenson B; Taioli E
JAMA Netw Open; 2021 Dec; 4(12):e2137508. PubMed ID: 34919136
[TBL] [Abstract][Full Text] [Related]
72. Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM).
Colucci G; Gebbia V; Galetta D; Riccardi F; Cariello S; Gebbia N
Br J Cancer; 1997; 76(11):1509-17. PubMed ID: 9400950
[TBL] [Abstract][Full Text] [Related]
73. Diagnostic performance of low-dose computed tomography screening for lung cancer over five years.
Veronesi G; Maisonneuve P; Spaggiari L; Rampinelli C; Pardolesi A; Bertolotti R; Filippi N; Bellomi M
J Thorac Oncol; 2014 Jul; 9(7):935-939. PubMed ID: 24922008
[TBL] [Abstract][Full Text] [Related]
74. Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial.
Brain K; Carter B; Lifford KJ; Burke O; Devaraj A; Baldwin DR; Duffy S; Field JK
Thorax; 2017 Oct; 72(10):912-918. PubMed ID: 28710339
[TBL] [Abstract][Full Text] [Related]
75. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
76. Different efficacy of CT screening for lung cancer according to histological type: analysis of Japanese-smoker cases detected using a low-dose CT screen.
Kondo R; Yoshida K; Kawakami S; Shiina T; Kurai M; Takasuna K; Yamamoto H; Koizumi T; Honda T; Kubo K
Lung Cancer; 2011 Dec; 74(3):433-40. PubMed ID: 21663995
[TBL] [Abstract][Full Text] [Related]
77. Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.
Westeel V; Foucher P; Scherpereel A; Domas J; Girard P; Trédaniel J; Wislez M; Dumont P; Quoix E; Raffy O; Braun D; Derollez M; Goupil F; Hermann J; Devin E; Barbieux H; Pichon E; Debieuvre D; Ozenne G; Muir JF; Dehette S; Virally J; Grivaux M; Lebargy F; Souquet PJ; Freijat FA; Girard N; Courau E; Azarian R; Farny M; Duhamel JP; Langlais A; Morin F; Milleron B; Zalcman G; Barlesi F
Lancet Oncol; 2022 Sep; 23(9):1180-1188. PubMed ID: 35964621
[TBL] [Abstract][Full Text] [Related]
78. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
Amaria RN; Prieto PA; Tetzlaff MT; Reuben A; Andrews MC; Ross MI; Glitza IC; Cormier J; Hwu WJ; Tawbi HA; Patel SP; Lee JE; Gershenwald JE; Spencer CN; Gopalakrishnan V; Bassett R; Simpson L; Mouton R; Hudgens CW; Zhao L; Zhu H; Cooper ZA; Wani K; Lazar A; Hwu P; Diab A; Wong MK; McQuade JL; Royal R; Lucci A; Burton EM; Reddy S; Sharma P; Allison J; Futreal PA; Woodman SE; Davies MA; Wargo JA
Lancet Oncol; 2018 Feb; 19(2):181-193. PubMed ID: 29361468
[TBL] [Abstract][Full Text] [Related]
79. Research in progress--LungSEARCH: a randomised controlled trial of surveillance for the early detection of lung cancer in a high-risk group.
Spiro SG; Hackshaw A;
Thorax; 2016 Jan; 71(1):91-3. PubMed ID: 26138736
[TBL] [Abstract][Full Text] [Related]
80. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.
Veronesi G; Bellomi M; Mulshine JL; Pelosi G; Scanagatta P; Paganelli G; Maisonneuve P; Preda L; Leo F; Bertolotti R; Solli P; Spaggiari L
Lung Cancer; 2008 Sep; 61(3):340-9. PubMed ID: 18308420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
